Eyenovia: Funding, Investors & Team (Oct 2026)
Eyenovia is a biopharmaceutical company founded in 2014 that offers a range of innovative topical eye treatments. They specialize in transforming the delivery of therapeutics for common eye conditions like glaucoma, dry eyes, and allergies. Eyenovia's unique technology allows for the development of new micro-therapeutics that minimize side effects and improve the effectiveness of treatments.
Eyenovia has raised $76.4M across 5 funding rounds on record, the most recent an undisclosed round of $50.0M announced in Jun 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eyenovia Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Eyenovia Funding Rounds
Eyenovia raised $15.0M in a Post-IPO Equity announced in Mar 2022.
2.3 years later, an undisclosed round of $5.0M was announced in Jun 2024.
2 months later, an undisclosed round of $5.1M was announced in Aug 2024.
3 months later, an undisclosed round of $1.3M was announced in Nov 2024.
7 months later, an undisclosed round of $50.0M was announced in Jun 2025.
Eyenovia Founders and Leadership Team
Contact details for the Eyenovia team: 1 of 1 has an email address on file.
Start 14-day free trial →Eyenovia Funding Compared to Other Biotechnology Startups
Eyenovia's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eyenovia in Biotechnology and New York
Companies Similar to Eyenovia
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Eyenovia Funding FAQs
What does Eyenovia do?
Eyenovia is a biopharmaceutical company founded in 2014 that offers a range of innovative topical eye treatments. They specialize in transforming the delivery of therapeutics for common eye conditions like glaucoma, dry eyes, and allergies. Eyenovia's unique technology allows for the development of new micro-therapeutics that minimize side effects and improve the effectiveness of treatments.
How much funding has Eyenovia raised?
Eyenovia has raised $76.4M across 5 rounds on record. The most recent is an undisclosed round of $50.0M announced in Jun 2025.
When did Eyenovia last raise funding?
Eyenovia's most recent funding round on record is an undisclosed round of $50.0M, announced in Jun 2025.
Who founded Eyenovia?
FundedIQ lists Sean Ianchulev (Founder) at Eyenovia.
Where is Eyenovia headquartered?
Eyenovia is based in New York, United States.
How many employees does Eyenovia have?
Eyenovia is in the 51-100 employee band.
How does Eyenovia's funding compare to other Biotechnology startups?
Eyenovia's latest round of $50.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Eyenovia Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eyenovia is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.